摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Acetic acid, nitrilotri-, trisodium salt

中文名称
——
中文别名
——
英文名称
Acetic acid, nitrilotri-, trisodium salt
英文别名
trisodium;2-[bis(carboxylatomethyl)amino]acetate
Acetic acid, nitrilotri-, trisodium salt化学式
CAS
——
化学式
C6H6NNa3O6
mdl
——
分子量
257.08
InChiKey
DZCAZXAJPZCSCU-UHFFFAOYSA-K
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -14.45
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    124
  • 氢给体数:
    0
  • 氢受体数:
    7

ADMET

毒理性
  • 致癌性证据
评估:对于亚硝基三乙酸的致癌性,人类中的证据不足。对于亚硝基三乙酸及其钠盐的致癌性,实验动物中有足够证据。总体评估:亚硝基三乙酸及其盐类可能对人类具有致癌性(2B组)。/亚硝基三乙酸及其盐类/
Evaluation: There is inadequate evidence in humans for the carcinogenicity of nitrilotriacetic acid and its salts. There is sufficient evidence in experimental animals for the carcinogenicity of nitrilotriacetic acid and its sodium salts. Overall evaluation: Nitrilotriacetic acid and its salts are possibly carcinogenic in humans (Group 2B). /Nitrilotriacetic acid and its salts/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 暴露途径
该物质可以通过吸入其气溶胶和通过吞食被吸收进人体。
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 吸入症状
灼热感。喉咙痛。咳嗽。呼吸困难。气短。
Burning sensation. Sore throat. Cough. Laboured breathing. Shortness of breath.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 皮肤症状
红肿。皮肤灼伤。疼痛。
Redness. Skin burns. Pain.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
毒理性
  • 眼睛症状
红斑。疼痛。严重的深度烧伤。
Redness. Pain. Severe deep burns.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
吸收、分配和排泄
基三乙酸盐在大鼠和狗中吸收良好,并以不变的形式通过尿液排出。在大鼠骨骼中与钙离子结合的该物质的量(8微克/克骨骼)仅占该组织24小时转换的0.007%,被认为不太可能对发育产生不利影响。
TRISODIUM AMINOTRIACETATE WAS WELL ABSORBED IN RATS AND DOGS, & EXCRETED UNCHANGED IN URINE. THE AMT (8 UG/G BONE), WHICH WAS INCORPORATED INTO RAT SKELETON IN COMBINATION WITH CA2+ REPRESENTED ONLY 0.007% OF THE 24 HR TURNOVER OF CALCIUM IN THAT TISSUE, AND WAS CONSIDERED UNLIKELY TO AFFECT DEVELOPMENT ADVERSELY.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
老鼠在饮食中分别添加了0.05、0.1、0.3、0.5、0.75或2%的硝基三乙酸酯,持续42天和30天。即使在尿液中NTA平等于或大于血浆的200倍时,硝基三乙酸酯在膀胱组织中的积累程度也不比心脏和肝脏更高。
RATS WERE GIVEN TRISODIUM NITRILOTRIACETATE AT DIETARY LEVELS OF 0.05, 0.1, 0.3, 0.5, 0.75, OR 2% FOR 42 & 30 DAYS. NITRILOTRIACETATE DID NOT ACCUMULATE IN BLADDER TISSUES TO ANY GREATER EXTENT THAN IN HEART AND LIVER, EVEN WHEN URINARY NTA LEVELS WERE EQUAL TO OR GREATER THAN 200 TIMES THOSE IN PLASMA.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
在全身自动放射性照片研究中,给NMRI白化小鼠静脉注射了0.93毫克的(1-(14)C-醋酸)NTA,三钠盐,并且给C57BI小鼠口服了相同剂量;在骨骼中发生了大量的放射性积累,这种积累持续了48小时,这是所研究的最长时间间隔。
In a whole body autoradiographic study, 0.93 Mg (1-(14)C-acetate) NTA, trisodium salt was administered intravenously to NMRI albino mice and the same amount orally to C57BI mice; heavy accumulation of radioactivity occurred in the skeleton, which persisted for 48 h, the longest interval studied.
来源:Hazardous Substances Data Bank (HSDB)

反应信息

点击查看最新优质反应信息

文献信息

  • Process for producing granular alkali metal nitrilotriacetate
    申请人:Solutia, Inc.
    公开号:US05861531A1
    公开(公告)日:1999-01-19
    There is disclosed a process for preparing highly absorptive granular alkali metal nitrilotriacetate by contacting NTA powder with a partially neutralizing amount of acid. A granular product having a majority of the granules, by weight, in the -12 to +80 mesh size range, which have a density of at least about 0.70 g/cc and an absorptivity in the absorptivity test in the range of above 12 ml/100 g is produced by contacting alkali metal nitrilotriacetate with acid, mixing the material to granulate it and then drying the granules. The acid may be added in either one or two steps. In the one step embodiment the acid addition time/mix time ratio is critical while in the two addition step embodiment mix time is not critical. However, in the two step embodiment the powder is first contacted is with dilute acid and the second contact step is with concentrated acid. A granular product having a density of at least about 0.70 g/cc, fewer than 15% fine material and an absorptivity in the range of from about 12-14 ml/100 g is produced.
    本发明揭示了一种制备高吸收性颗粒状碱NTA的方法,即通过将NTA粉末与部分中和量的酸接触。通过将碱NTA与酸接触,混合材料以制成颗粒,并然后干燥颗粒,从而产生大多数颗粒重量在-12至+80目尺寸范围内,密度至少约为0.70 g / cc,吸收性在吸收性测试范围内大于12 ml / 100 g的颗粒产品。酸可以分为一步或两步添加。在一步实施方式中,酸添加时间/混合时间比关键,而在两步添加实施方式中,混合时间不关键。但是,在两步实施方式中,首先将粉末与稀酸接触,第二个接触步骤是与浓酸接触。产生的颗粒产品具有密度至少约为0.70 g / cc,少于15%的细颗粒,吸收性在约12-14 ml / 100 g的范围内。
  • AMINOCARBOXYLATE POWDERS WITH IMPROVED PURITY AND FLOWABILITY PROPERTIES
    申请人:Moore, JR. J. W.
    公开号:US20110288332A1
    公开(公告)日:2011-11-24
    Provided is a method for preparing stable free flowing solid aminocarboxylate chelants by adding to a chelant that contains residual alkaline metal hydroxide a free or partially neutralized carboxylic acid such that the free or partially neutralized acid neutralizes at least a portion of the alkaline metal hydroxide; and isolating therefrom the free-flowing solid chelant.
    提供了一种制备稳定自由流动的固态羧酸螯合剂的方法,该方法是向含有残留碱性属氢氧化物的螯合剂中添加一个自由或部分中和的羧酸,使得自由或部分中和的酸至少中和部分碱性属氢氧化物;然后从中分离出自由流动的固态螯合剂
  • Aminocarboxylate powders with improved purity and flowability properties
    申请人:Moore, Jr. J. Weldon
    公开号:US09012684B2
    公开(公告)日:2015-04-21
    Provided is a method for preparing stable free flowing solid aminocarboxylate chelants by adding to a chelant that contains residual alkaline metal hydroxide a free or partially neutralized carboxylic acid such that the free or partially neutralized acid neutralizes at least a portion of the alkaline metal hydroxide; and isolating therefrom the free-flowing solid chelant.
    提供了一种制备稳定自由流动的固态羧酸螯合剂的方法,该方法是通过向含有残留碱性属氢氧化物的螯合剂中添加自由或部分中和的羧酸,使得自由或部分中和的酸中和至少部分碱性属氢氧化物;然后从中分离出自由流动的固态螯合剂
  • METAL PRECURSOR AND METAL PRECURSOR INK USING THE SAME
    申请人:PESOLVE CO., LTD.
    公开号:US20150336878A1
    公开(公告)日:2015-11-26
    Provided are a metal precursor containing an oxime group, which is represented by general formula 1, and a metal precursor ink containing same. The metal precursor ink according to the present invention enhance metal content, induce intramolecular and/or intermolecular complexation, thereby enabling low temperature sintering with excellent solubility and stability. The metal precursor ink according to the present invention can be used to form a metal wire with a desired shape. Therefore, the metal precursor ink can find applications in the field of printed electronics, particularly various electrodes, such as mesh type transparent electrodes.
    提供一种含有基团的属前体,其表示为通式1,并且包含相同的属前体油墨。本发明的属前体油墨增强了属含量,诱导分子内和/或分子间络合作用,从而实现低温烧结,具有优异的溶解性和稳定性。本发明的属前体油墨可用于形成所需形状的属线。因此,该属前体油墨可以在印刷电子领域中找到应用,特别是各种电极,如网格型透明电极。
  • SPANGGORD R. J.; TYSON C. A., SCIENCE, 1979, 204, NO 4397, 1081-1082
    作者:SPANGGORD R. J.、 TYSON C. A.
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸